ReproCyte is a stem cell research company focused on the application potential of adult stem cells for regenerative cellular therapy. ReproCyte has done extensive research on identifying and developing innovative sources for cell replacement therapy using a variety of cell types, including germ line stem cells and stem cells from bone marrow and adipose tissue. Currently, ReproCyte is working to find an efficient stem cell transplantation protocol for improvement of kidney function in Alport Syndrome using bone marrow transplantation and/or germ line stem cells. In addition, we are trying to produce an alternative cell source for treatment of Parkinson’s disease using germ line stem cells. ReproCyte’s research team has years of experience with the characterization and identification of germ line stem cells.